AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Hugin Ad hoc announcement according to 15 WpHG: Misc. matters: Jerini AG: Jerini AG Sets Offer Price for IPO.

Europe Intelligence Wire

| November 01, 2005 | COPYRIGHT 2005 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Hugin)

Ad-hoc announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- -------------- Ad-hoc Announcement pursuant 15 WpHG (German Securities Trading Act)

Berlin, November 1, 2005. - Jerini AG together with Credit Suisse First Boston and Deutsche Bank as Joint Global Coordinators and Joint Bookrunners has set the offer price of its initial public offering at 3.20 per share. A total of 15.5 million shares from a capital increase and 0.6 million additional shares from the over-allotment option have been allocated. Before exercise of the greenshoe option and the corresponding potential capital increase to cove over-allotments, the volume of placement will amount to 49.6 million. The company will receive the entire net proceeds from the transaction. Additional Information: ISIN: DE0006787476 Stock Exchange: Frankfurt Stock Exchange, Prime Standard Company For more information, please visit the Jerini website at www.jerini.de. Jerini AG Stacy Wiedenmann Director Investor Relations & Corporate Communications Invalidenstr. 117 10115 Berlin Tel.: + 49 30 97893 285 Fax.: + 49 30 97893 105 wiedenmann@jerini.de Important Note: This document, and the information contained therein, is directed solely at persons in Germany. This document does not constitute an offer to sell or a solicitation of an offer to buy securities. The offering in Germany is solely made through and on the basis of a prospectus to be published. The prospectus in the German language approved by the German Federal Financial Services Supervisory Authority ...

Related articles from newspapers, magazines, journals, and more
Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document.
Press release article from: PR Newswire August 13, 2008 700+ words
...offer to sell shares in Jerini AG, nor an offer to purchase...holders of shares in Jerini AG are strongly advised...holders of shares in Jerini AG may review these documents...Jerini Shares outside the United States, other than pursuant...
Jerini AG Presents Clinical Development Update for Icatibant in the Treatment...
Press release article from: PR Newswire March 6, 2006 700+ words
...PRNewswire-FirstCall/ -- Jerini AG (FSE: JI4) announced...countries including the United States, Canada, Australia...marketing approval in the United States and Europe by the end...Schneider-Mergener. About Jerini AG Jerini AG is a pharmaceutical...
Jerini AG Completes Euro 31 Million Financing Round.
Press release article from: PR Newswire June 9, 2004 700+ words
...BERLIN, June 9 /PRNewswire/ -- Jerini AG, a drug discovery and development...Harris (New York/Houston, United States), the PolyTechnos Funds (Munich...convincing management." About Jerini AG Jerini AG (http://www.jerini.com...
Jerini AG and Merck KGaA Announce Collaboration to Develop Small Molecule...
Press release article from: Business Wire January 28, 2004 700+ words
...BUSINESS WIRE)--Jan. 28, 2004 Jerini AG and Merck KGaA today announced a collaboration...Mergener, PhD, Chief Executive Officer, Jerini AG. "It validates our novel Peptides...year over the next several years. About Jerini AG: Jerini AG (www.jerini.com) is...
Jerini AG Successfully Raises Additional EUR 15.5 Million to Support...
Press release article from: Business Wire February 14, 2005 700+ words
BERLIN -- Jerini AG, the Berlin-based drug discovery and development company, announced...round," said Dr. Hubert Birner, General Partner of TVM. About Jerini AG Jerini AG is a biopharmaceutical company based in Berlin, Germany focused...
Jerini AG Announces Research Collaboration with Alcon.
Press release article from: Business Wire January 19, 2005 700+ words
BERLIN, Germany -- Jerini AG has entered into a strategic discovery and development collaboration...says Adi Hoess, Chief Commercial Officer of Jerini. About Jerini AG Jerini AG (www.jerini.com) is a drug discovery and development company...
Jerini AG Presents Positive Macular Degeneration Data.
Press release article from: Business Wire April 20, 2005 700+ words
...Advancement of the Company's Compound into Clinical Trials Jerini AG, a biopharmaceutical company focused on the discovery...Head of Research and Development at Jerini. About Jerini AG Jerini AG is a biopharmaceutical company based in Berlin, Germany...
Jerini AG-Company Report.
Press release article from: M2 Presswire February 5, 2009 700+ words
...PRESSWIRE-5 February 2009-www.companiesandmarkets.com: Jerini AG-Company Report(C)1994-2009 M2 COMMUNICATIONS LTD RDATE:05022009 -www.companiesandmarkets.com adds new report: Jerini AG-Company Report Private Company Reports provide up to date...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA